toxicité (1) qualité de vie (1) industrie pharmaceutique (1) besoin (1) marketing (1) démocratie (1) décision (1) coût (1) cancer (1) survie (1) États-Unis (1) France (1) Paris (1) Belgique (1) Diagnosis (1) Decision making (1) Context (1) Marketing (1) Treatment (1) History (1) Cancer (1) Methods (1) Charts, diagrams, etc (1) Transparency (1) Imaginary places (1) Expertise (1) Views (1) Survival (1) Quality of life (1) Progress (1)